Enzalutamide and Nirmatrelvir/Ritonavir Interaction

Drug interaction information between Enzalutamide and Nirmatrelvir/Ritonavir.

Enzalutamide and Nirmatrelvir/Ritonavir have a documented major interaction in FDA labeling.

FDA drug labeling documents a major-severity interaction between Enzalutamide and Nirmatrelvir/Ritonavir. This page displays the available source-record category and label text. The category is not an individual risk estimate or medication-combination direction.

Drug A

Enzalutamide

Androgen Receptor Inhibitor

Drug B

Nirmatrelvir/Ritonavir

Antiviral (Protease Inhibitor Combination)

How They Interact

Enzalutamide lowers the levels of nirmatrelvir/ritonavir in your body by speeding up how it is processed. This can prevent the medicine from fighting the virus effectively.

FDA Label Information

Anticancer drugs apalutamide, enzalutamide ↓ nirmatrelvir/ritonavir Co-administration contraindicated due to potential loss of virologic response and possible resistance [see Contraindications (4) ].

Enzalutamide Also Interacts With

View all Enzalutamide interactions →

Frequently Asked Questions

What SPL severity band is on file for Enzalutamide + Nirmatrelvir/Ritonavir?

Compiled FDA labeling labels this pair major. That is a source-record field, not an individual medication-combination decision.

Which drug in this pair has the larger labeled-interaction portfolio?

Nirmatrelvir/Ritonavir has 86 labeled pairs on file vs Enzalutamide's 4. In the major band specifically: Enzalutamide has 1; Nirmatrelvir/Ritonavir has 23 (also Simvastatin, Lovastatin, Sildenafil, Carbamazepine).

What mechanism field is on file for Enzalutamide and Nirmatrelvir/Ritonavir?

Enzalutamide lowers the levels of nirmatrelvir/ritonavir in your body by speeding up how it is processed. This can prevent the medicine from fighting the virus effectively.

Nirmatrelvir/Ritonavir carries more major-labeled pairs than Enzalutamide

SPL source-record counts only. This page's band is major · classes on file: Enzalutamide (Androgen Receptor Inhibitor); Nirmatrelvir/Ritonavir (Antiviral (Protease Inhibitor Combination)).

Nirmatrelvir/Ritonavir has 23 major-labeled pairs vs Enzalutamide's 1.

Enzalutamide

1 major · 0 moderate · 3 minor · 4 total

Enzalutamide has no other major-band peer in this dataset besides Nirmatrelvir/Ritonavir.

Nirmatrelvir/Ritonavir

23 major · 30 moderate · 33 minor · 86 total

Sources: FDA Drug Labels (SPL) via openFDA (2026). This is for informational purposes only and is not medical advice. This registry does not provide individual medication-combination directions.